Formycon (Germany) Today
| FYB Stock | 54.50 0.30 0.55% |
Performance6 of 100
| Odds Of DistressLess than 34
|
Formycon is selling for under 54.50 as of the 30th of January 2025; that is 0.55 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 54.2. Formycon has about a 34 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
Moving against Formycon Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Formycon Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Formycon's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Formycon or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| COO CEO | Stefan Glombitza |
| Business Concentration | Health Care, Biotechnology (View all Sectors) |
Formycon AG (FYB) is traded on XETRA Stock Exchange in Germany and employs 146 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.23 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Formycon's market, we take the total number of its shares issued and multiply it by Formycon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Formycon AG has 15.06 M outstanding shares.
Formycon AG has accumulated about 25.03 M in cash with (14.18 M) of positive cash flow from operations.
Check Formycon Probability Of Bankruptcy
Ownership AllocationFormycon holds a total of 15.06 Million outstanding shares. Formycon AG retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Formycon Ownership Details
Formycon AG Risk Profiles
Although Formycon's alpha and beta are two of the key measurements used to evaluate Formycon's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.85 | |||
| Semi Deviation | 1.85 | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.62 |
Formycon Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Formycon without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Formycon Corporate Executives
Elected by the shareholders, the Formycon's board of directors comprises two types of representatives: Formycon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Formycon. The board's role is to monitor Formycon's management team and ensure that shareholders' interests are well served. Formycon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Formycon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nicolas Combe | CoFounder CFO | Profile | |
| FriedrichWilhelm Steinweg | CoFounder | Profile |
Additional Tools for Formycon Stock Analysis
When running Formycon's price analysis, check to measure Formycon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Formycon is operating at the current time. Most of Formycon's value examination focuses on studying past and present price action to predict the probability of Formycon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Formycon's price. Additionally, you may evaluate how the addition of Formycon to your portfolios can decrease your overall portfolio volatility.